[Retracted] Predicting Risk of Insulin Resistance in a Chinese Population with Polycystic Ovary Syndrome: Designing and Testing a New Predictive Nomogram

Table 1

Differences between demographic and clinical characteristics of IR and non-IR groups.

Demographic characteristics
	Insulin resistance (101)	Noninsulin resistance (44)	Total (145)
Age (years)
<20	4 (66.67)	2 (33.33)	6 (4.14)
20-30	65 (66.33)	33 (33.67)	98 (67.59)
30-40	32 (78.05)	9 (21.95)	41 (28.29)
Education level
Secondary (9-12 years)	39 (67.24)	19 (32.76)	58 (40.00)
Higher (>12 years)	62 (71.26)	25 (28.74)	87 (60.00)
Occupation
Employed	45 (58.44)	32 (41.56)	77 (53.10)
Unemployed	56 (82.35)	12 (17.65)	68 (46.90)
Disease durations (years)
0-1	25 (56.82)	19 (43.18)	44 (30.34)
1-5	63 (72.41)	24 (27.59)	87 (60.00)
5-10	12 (92.31)	1 (7.69)	13 (8.97)
>10	1 (100)	0 (0)	1 (0.69)
BMI
≥28	69 (79.31)	18 (20.69)	87 (60.00)
≥24,<28	28 (59.57)	19 (40.43)	47 (32.41)
18.5-24	4 (40.00)	6 (60.00)	10 (6.90)
<18.5	0 (0)	1 (100)	1 (0.69)
WHR
<0.8	16 (66.67)	8 (33.33)	24 (16.55)
≥0.8	85 (70.25)	36 (29.75)	121 (83.45)
Clinic characteristics
TC
Normal	93 (69.40)	41 (30.60)	134 (92.41)
Abnormal	8 (72.73)	3 (27.27)	11 (7.59)
TG
Normal	59 (67.82)	28 (32.18)	87 (60.00)
Abnormal	41 (71.93)	16 (28.07)	58 (40.00)
LDL
Normal	67 (67.67)	32 (32.32)	99 (68.28)
Abnormal	34 (73.91)	12 (26.09)	46 (31.72)
Hypertension
Normal	77 (66.38)	39 (33.62)	116 (80.00)
Abnormal	24 (82.76)	5 (17.24)	29 (20.00)
Current use of metformin
No	83 (72.81)	31 (17.19)	114 (78.62)
Yes	18 (58.06)	13 (41.94)	31 (21.38)
Lifestyle (day)
Sleeping duration
<6 h	28 (66.67)	14 (33.33)	42 (28.97)
≥6 h	73 (70.87)	30 (29.13)	103 (71.03)
Mealtime
<30 min	42 (79.25)	11 (20.75)	53 (36.55)
≥30 min	59 (64.13)	33 (35.87)	92 (63.45)
Activities
<30 min	62 (81.58)	14 (18.42)	76 (52.41)
≥30 min	39 (56.52)	30 (43.48)	69 (47.59)